MAM
CUE icon

Monaco Asset Management’s Cue Biopharma CUE Stock Holding History

Monaco Asset Management’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,440
Closed -$314K – 77
2024
Q2 		$314K Sell
8,440
-2,718
-24% -$134K 0.05% 60
2024
Q1 		$633K Sell
11,158
-250
-2% -$17.6K 0.19% 49
2023
Q4 		$904K Sell
11,408
-583
-5% -$41.7K 0.27% 58
2023
Q3 		$827K Sell
11,991
-356
-3% -$34.8K 0.25% 52
2023
Q2 		$1.35M Sell
12,347
-3,198
-21% -$376K 0.38% 45
2023
Q1 		$1.66M Sell
15,545
-1,028
-6% -$98K 0.51% 40
2022
Q4 		$1.42M Buy
16,573
+1,278
+8% +$117K 0.43% 46
2022
Q3 		$1.02M Buy
15,295
+500
+3% +$43K 0.39% 45
2022
Q2 		$1.1M Buy
14,795
+13,295
+886% +$1.56M 0.48% 38
2022
Q1 		$220K Buy
+1,500
New +$318K 0.09% 46

Other funds holding CUE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Monaco Asset Management's CUE Position: Q3 2024 in Review

Monaco Asset Management sold out of Cue Biopharma (CUE) in Q3 2024, closing a stake of 8,440 shares — an estimated $314K sold.

Monaco Asset Management first reported a position in CUE in Q1 2022 and held it in 10 quarters. The position peaked at $1.66M in Q1 2023. 50 funds tracked by Wall St. Rank hold CUE as of Q3 2024.

  • Monaco Asset Management reported no remaining Cue Biopharma position as of Q3 2024 after selling out during the quarter.
  • Monaco Asset Management sold 8,440 Cue Biopharma shares in Q3 2024, an estimated $314K.
  • Monaco Asset Management first reported a position in Cue Biopharma in Q1 2022 and held it in 10 quarters.
  • Monaco Asset Management's Cue Biopharma position peaked at $1.66M in Q1 2023.
  • 50 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2024.

Based on Monaco Asset Management's 13F filing for Q3 2024, filed 7 Nov 2024.